AstraZeneca raises its earnings guidance and share buy-back target

For the second time this year, AstraZeneca Plc has raised its guidance for earnings per share in 2010 even as it anticipates a slight decline in revenue and downward pressure on prices in Europe from healthcare reforms. The Anglo-Swedish multinational also said that it is raising its target for the repurchase of its shares on the market to $2 billion, up from $1 billion, and will be paying an interim dividend of $0.70 per share.

Location